RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Public ClinicalTrials.gov record NCT02228889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction
Study identification
- NCT ID
- NCT02228889
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Jeffrey Janis
- Other
- Enrollment
- 46 participants
Conditions and interventions
Interventions
- Abdominal wall reconstruction with Strattice Procedure
- Abdominal wall reconstruction with XenMatrix Procedure
- Assess Surgical Site Occurrences at 1 year postoperatively Other
- Assess Surgical Site Occurrences at 30 days postoperatively Other
- Assess bulge at 1 year postoperatively Other
- Assess bulge at 30 days postoperatively Other
- Assess hernia recurrence at 1 year postoperatively Other
- Assess hernia recurrence at 30 days postoperatively Other
- Assess overall complications at 1 year postoperatively Other
- Assess overall complications at 30 days postoperatively Other
- Assess pain intensity at last office visit preoperatively Other
- Assess pain interference at last office visit preoperatively Other
- Assess pain interference postoperatively Other
- Assess patient pain intensity postoperatively Other
- Assess patient quality of life at last office visit preoperatively Other
- Assess physical functioning at last office visit preoperatively Other
- Assess physical functioning postoperatively Other
- Assess quality of life postoperatively Other
- Strattice Device
- XenMatrix Device
Procedure · Other · Device
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2014
- Primary completion
- Mar 26, 2025
- Completion
- Mar 26, 2025
- Last update posted
- Jun 5, 2025
2015 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02228889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02228889 live on ClinicalTrials.gov.